| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.085 | 0.6 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.09 | 0.6 |